about

Norn Group’s mission is to maximize the probability that by 2060 we have interventions that will let a 60 year old live for another 60 years without a decline in health and function.

Read our thesis

A young man with short, styled hair and blue eyes, wearing a black shirt, smiling with a dark, leafy background.

Martin Borch Jensen

Founder, President

In addition to my work at Norn, I’m the founder and CSO of Gordian Biotechnology, the first in vivo therapeutic screening platform to radically improve drug development for complex diseases of aging. My focus is on developing technologies to interrogate the full network of aging processes inside living organisms. This includes multiplexed measurement of complex states, interpretable perturbations, and context-aware data models.

Previously, I was an academic working on a range of cellular mechanisms involved in aging: mitochondrial function, NAD metabolism, DNA damage signaling and other stress responses.

Meet the Norn team

Effie Klimi

Communication & Media

I joined Norn because I want to help make longevity felt in proportion to its importance.
A smart and complex idea rarely travels far on its own merits. People are moved by stories, by things that resonate with their aesthetics more deeply than argument. Longevity is one of the clearest examples of this. So much of suffering is bound up with aging, and yet the idea does not land in the wider culture with anything like the seriousness it deserves.

Before joining the team, I finished my PhD in vascular RNA therapeutics and viral vectors at the University of Edinburgh.

A young man with dark hair, a beard, and a big smile sitting at a table, holding a black mug, wearing a dark T-shirt, a wristwatch, and a ring, with a window and dark wall in the background.

Sufal Deb

Scientific Chief of Staff

My research and love for bioacoustics made me wonder, “Why do we lose our senses and perception of our world as we age?" The journey to answer this question yielded more roadblocks, things that needed to be done first. I started translating and communicating progress in the field, building interdisciplinary community, developing aging science education, and increasing accessibility for people to contribute to aging biotech.

Prior to my work today, I co-founded LongX.bio, was a biologist working with bats, and worked in biotech tackling bottlenecks in product, ops, and biz dev.

Tara Mei

Director of Impetus Grants

The experience of watching a loved one lose their memory, personality, and dignity to a disease of aging has driven home for me the degree to which diseases of aging cause suffering. I look forward to doing whatever I can to help people live longer lives in good health.

I am currently on the founding team at Covalent.bio and consult for various deep tech companies. Previously, I served as Optispan's Head of Strategy, led longevity recruitment, research, and field-building initiatives at Norn Group, and worked in research at the National University of Singapore. I studied biology and classical piano at Princeton, Cambridge, Oxford, and the Hochschule für Musik Basel.